DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration. (November 2019)
- Record Type:
- Journal Article
- Title:
- DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration. (November 2019)
- Main Title:
- DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration
- Authors:
- Son, Jaewoo
Kim, Junhyung
Lee, Kyungwoo
Hwang, Jangsun
Choi, Yonghyun
Seo, Youngmin
Jeon, Hojeong
Kang, Ho Chang
Woo, Heung-Myung
Kang, Byung-Jae
Choi, Jonghoon - Abstract:
- Graphical abstract: Abstract: In this study, we developed aptamer-conjugated hydroxyapatite (Apt-HA) that promotes bone regeneration and angiogenesis. The 3R02 bivalent aptamer specific to vascular endothelial growth factor (VEGF) was grafted to the hydroxyapatite (HA) surface. Apt-HA was tested for its VEGF protein capture ability to determine the optimal aptamer concentration immobilized on the HA. Apt-HA showed higher VEGF protein capture ability, and faster growth of human umbilical vein endothelial cell (HUVEC) compared to a neat HA with no cytotoxic effects on human osteoblasts. To examine in vivo angiogenesis and bone regeneration, Apt-HA and HA were bilaterally implanted into rabbit tibial metaphyseal defects and analyzed after eight weeks using micro-CT, histology, and histomorphometry. Apt-HA showed significantly increased the volume of new bones, the percentage of bone, and the density of bone mineral in cortical bone. Apt-HA also exhibited the enhanced bone formation at the cortical region in a histomorphometric analysis. Finally, Apt-HA showed significantly increased blood vessel number compared to a neat HA. In summary, the engineered Apt-HA has potential as a bone graft material that may simultaneously promote bone regeneration and angiogenesis. Statement of Significance: This work presents a functional hydroxyapatite bone graft using a DNA-based aptamer which overcomes the limitations of existing bone graft materials, which use bound signaling peptides. DNAGraphical abstract: Abstract: In this study, we developed aptamer-conjugated hydroxyapatite (Apt-HA) that promotes bone regeneration and angiogenesis. The 3R02 bivalent aptamer specific to vascular endothelial growth factor (VEGF) was grafted to the hydroxyapatite (HA) surface. Apt-HA was tested for its VEGF protein capture ability to determine the optimal aptamer concentration immobilized on the HA. Apt-HA showed higher VEGF protein capture ability, and faster growth of human umbilical vein endothelial cell (HUVEC) compared to a neat HA with no cytotoxic effects on human osteoblasts. To examine in vivo angiogenesis and bone regeneration, Apt-HA and HA were bilaterally implanted into rabbit tibial metaphyseal defects and analyzed after eight weeks using micro-CT, histology, and histomorphometry. Apt-HA showed significantly increased the volume of new bones, the percentage of bone, and the density of bone mineral in cortical bone. Apt-HA also exhibited the enhanced bone formation at the cortical region in a histomorphometric analysis. Finally, Apt-HA showed significantly increased blood vessel number compared to a neat HA. In summary, the engineered Apt-HA has potential as a bone graft material that may simultaneously promote bone regeneration and angiogenesis. Statement of Significance: This work presents a functional hydroxyapatite bone graft using a DNA-based aptamer which overcomes the limitations of existing bone graft materials, which use bound signaling peptides. DNA aptamer immobilized hydroxyapatite enhances the in vitro proliferation of human umbilical vascular endothelial cells as well as in vivo angiogenesis and bone regeneration. DNA aptamer immobilized hydroxyapatite shows no cytotoxic effect on human osteoblasts. … (more)
- Is Part Of:
- Acta biomaterialia. Volume 99(2019)
- Journal:
- Acta biomaterialia
- Issue:
- Volume 99(2019)
- Issue Display:
- Volume 99, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 99
- Issue:
- 2019
- Issue Sort Value:
- 2019-0099-2019-0000
- Page Start:
- 469
- Page End:
- 478
- Publication Date:
- 2019-11
- Subjects:
- Apt-HA aptamer-conjugated hydroxyapatite -- HA hydroxyapatite -- HBSS Hank's balanced salt solution -- HUVEC human umbilical vascular endothelial cells -- VEGF vascular endothelial growth factor -- BV/TV bone volume/total volume -- BMD bone mineral density -- Micro-CT micro-computed tomography
Hydroxyapatite -- Aptamer -- Crosslinker -- Angiogenesis -- Bone regeneration
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17427061 ↗
http://www.elsevier.com/wps/find/journaldescription.cws%5Fhome/702994/description ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.actbio.2019.08.047 ↗
- Languages:
- English
- ISSNs:
- 1742-7061
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0602.900500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23150.xml